Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of <i>Tripterygium wilfordii</i> against Pulmonary Artery Hypertension

<div>The schematic diagram of molecular docking. (a) Kaempferol and ICP3-CASP3; (b) triptolide and ICP3-CASP3; (c) kaempferol and IUKO-PARP1; (d) triptolide and IUKO-PARP1.</div>

Evidence-Based Complementary and Alternative Medicine

fig9

Figure 9

Figure 9: Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of <i>Tripterygium wilfordii</i> against Pulmonary Artery Hypertension 

Figure 9 | Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of Tripterygium wilfordii against Pulmonary Artery Hypertension 